Ascendis Pharma A/S (BVMF:A1SN34)
Brazil · Delayed Price · Currency is BRL 76.05
-2.52 (-3.21%)
At close: Mar 24, 2026
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of 68.09 billion as of April 30, 2026.
Market Cap
68.09B
Enterprise Value
69.59B
Revenue
4.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
76.05
Market Cap Chart
Since April 20, 2026, Ascendis Pharma's market cap has decreased from 75.51B to 68.09B, a decrease of -9.82%. That is a compound annual growth rate of -98.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 68.09B | -0.79% |
| Apr 28, 2026 | 68.63B | -1.53% |
| Apr 27, 2026 | 69.70B | -1.79% |
| Apr 24, 2026 | 70.97B | 3.23% |
| Apr 23, 2026 | 68.75B | -3.12% |
| Apr 22, 2026 | 70.96B | -3.92% |
| Apr 21, 2026 | 73.86B | -2.18% |
| Apr 20, 2026 | 75.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 84.79B |
| Raia Drogasil | 39.19B |
| Hypera | 14.37B |
| Fleury | 8.71B |
| Odontoprev | 8.01B |
| Diagnósticos da América | 3.92B |
| Empreendimentos Pague Menos | 3.73B |
| Blau Farmacêutica | 2.36B |